GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (WBO:BAYN) » Definitions » Cyclically Adjusted Revenue per Share

Bayer AG (WBO:BAYN) Cyclically Adjusted Revenue per Share : €53.96 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Bayer AG Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bayer AG's adjusted revenue per share for the three months ended in Mar. 2025 was €13.984. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €53.96 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Bayer AG's average Cyclically Adjusted Revenue Growth Rate was -1.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bayer AG was 3.90% per year. The lowest was 0.30% per year. And the median was 2.25% per year.

As of today (2025-05-25), Bayer AG's current stock price is €24.45. Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €53.96. Bayer AG's Cyclically Adjusted PS Ratio of today is 0.45.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 2.93. The lowest was 0.35. And the median was 1.21.


Bayer AG Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted Revenue per Share Chart

Bayer AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.85 50.23 53.87 54.51 54.20

Bayer AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.81 54.83 54.46 54.20 53.96

Competitive Comparison of Bayer AG's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PS Ratio falls into.


;
;

Bayer AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer AG's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=13.984/127.7792*127.7792
=13.984

Current CPI (Mar. 2025) = 127.7792.

Bayer AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 14.437 100.417 18.371
201509 13.328 100.417 16.960
201512 13.635 99.717 17.472
201603 14.335 100.017 18.314
201606 14.309 100.717 18.154
201609 9.986 101.017 12.632
201612 10.390 101.217 13.117
201703 11.109 101.417 13.997
201706 9.844 102.117 12.318
201709 9.062 102.717 11.273
201712 9.707 102.617 12.087
201803 10.319 102.917 12.812
201806 10.354 104.017 12.719
201809 9.449 104.718 11.530
201812 10.560 104.217 12.947
201903 12.500 104.217 15.326
201906 10.912 105.718 13.189
201909 10.006 106.018 12.060
201912 10.942 105.818 13.213
202003 13.075 105.718 15.804
202006 10.234 106.618 12.265
202009 8.658 105.818 10.455
202012 10.174 105.518 12.320
202103 12.549 107.518 14.914
202106 11.048 108.486 13.013
202109 9.956 109.435 11.625
202112 11.317 110.384 13.100
202203 14.901 113.968 16.707
202206 13.048 115.760 14.403
202209 11.483 118.818 12.349
202212 12.215 119.345 13.078
202303 14.646 122.402 15.289
202306 11.242 123.140 11.665
202309 10.527 124.195 10.831
202312 12.074 123.773 12.465
202403 14.011 125.038 14.318
202406 11.343 125.882 11.514
202409 10.146 126.198 10.273
202412 11.939 127.041 12.008
202503 13.984 127.779 13.984

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bayer AG  (WBO:BAYN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bayer AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=24.45/53.96
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 2.93. The lowest was 0.35. And the median was 1.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bayer AG Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (WBO:BAYN) » Definitions » Cyclically Adjusted Revenue per Share
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm's crop science business sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.